Stock listing

Sandoz Group Ltd

Selected listing: SDZ · SIX · CHF · CH

Sandoz Group Ltd (SIX Swiss: SDZ), Health Technology. Latest release Sep 29, 2026: Sandoz opens advanced high-volume drug substance manufacturing centre…

SDZ:SIXCHFCHUpdated October 2, 2026

Ticker: SIX Swiss: SDZ
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: SIX Swiss
Currency: CHF

About Sandoz Group Ltd

Sandoz Group Ltd, traded under the ticker SDZ, is a public company based in Switzerland. Sandoz specializes in generic pharmaceuticals and biosimilars, contributing to the healthcare sector by providing accessible medication options.

Latest news from Sandoz Group Ltd

Sandoz opens advanced high-volume drug substance manufacturing centre in Lendava, significantly strengthening in-house capacity and flexibility across leading European biosimilar network

September 29, 2026

Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines

September 18, 2026

Sandoz issues EUR 500 million bond

September 14, 2026

Sandoz invests in new drug substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity

September 8, 2026

Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline

August 16, 2026

All Sandoz Group Ltd news →

Events

Replays

Sandoz Group Ag S/Adr (SDZNY) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 03:30 AM ET
Watch
Sandoz Group Ag S/Adr (SDZNY) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 03:30 AM ET
Watch
Sandoz Group Ag S/Adr (SDZNY) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 03:30 AM ET
Watch

Research Sandoz Group Ltd

Sandoz Group Ltd company profile

View the public company page for Sandoz Group Ltd on 6ix.

Sandoz Group Ltd news

Read company news and market updates connected to Sandoz Group Ltd.

Sandoz Group Ltd investor events

Find investor webinars, events, and replay context for Sandoz Group Ltd.